NCT02217371

Brief Summary

In a previous protocol, we highlighted an excessive daytime sleepiness at the Maintenance of Wakefulness Tests (MWT) in 36% of adult Attention Deficit Disorder with or without Hyperactivity (ADHD) patients. In 40% of cases this sleepiness was associated with a sleep disorder objectified by polysomnography (PSG): apnea hypopnea syndrome (AHI) ≥ 10/h and / or Periodicals Movements of Lower Limb (PLMI) ≥ 15/h. However, among patients with no sleep disorder PSG, we can question the central origin of the Excessive Daytime Sleepiness. Thus, we wish to determine potential changes in the regulation of sleep / wake cycle through a protocol of extended wake. The principal objective is to compare the objective sleepiness in sleepy patients with ADHD and healthy subjects during a protocol of extended wake. It's an observational study of interventional type realized in patient with ADHD syndrome deprived of psychostimulant treatment (for 72 hours) and healthy subject, investigating the implication of the homeostatic and circadian systems in the preservation of awakening.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2014

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 5, 2014

Completed
3 months until next milestone

First Posted

Study publicly available on registry

August 15, 2014

Completed
18 days until next milestone

Study Start

First participant enrolled

September 2, 2014

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2017

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2017

Completed
Last Updated

August 10, 2017

Status Verified

August 1, 2017

Enrollment Period

2.7 years

First QC Date

May 5, 2014

Last Update Submit

August 8, 2017

Conditions

Keywords

ADHD PatientHealthy subjectsSleepinessPSGMWTEEGcognitive tests

Outcome Measures

Primary Outcomes (1)

  • Comparison of objective sleepiness

    Comparison of objective sleepiness in sleepy patients with ADHD and healthy subjects during a protocol of extended wake.

    at inclusion (day 0)

Secondary Outcomes (4)

  • Theta-alpha band of EEG sleep

    At inclusion (Day 0)

  • Amplitude and phase of internal temperature

    At inclusion (day 0)

  • Score of Karolinska Sleepiness Scale (subjective measure of sleepiness)

    At inclusion (day 0)

  • Results of the neuropsychological tests

    At inclusion (day 0)

Study Arms (2)

ADHD patient

EXPERIMENTAL
Other: Neuropsychological tests

Healthy volunteers

ACTIVE COMPARATOR
Other: Neuropsychological tests

Interventions

The tests are : Go/NoGo paradigm, Continuous Performance Test (CPT) II , Wisconsin Card Sorting Test (WCST), virtual CPT, Classic and virtual Stroop, PSG, MWT These tests will be repeated during 32h each 4h (T0h, T4h, T8h, T12h, T16h, T20h, T24h, T28h et T32h).

ADHD patientHealthy volunteers

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • For ADHD patient:
  • Patients male or feminine, from 18 to 50 years old,
  • Patient respondent in the criterion current diagnosis of the ADHD according to the Diagnostic and Statistical Manual of Mental Disorders (DSM) IV-TR,
  • Meeting the criteria diagnosis of ADHD in the childhood, estimated by the interview " Conners'Adult ADHD Diagnostic Interview for DSM-IV " (CAADID),
  • Patient presenting a total score ≥ 20 at CAARS With at least 6 items of money scales inattention or hyperactivity ≥ 2,
  • Patients deprived of any psychostimulants for 72 hours,
  • Presenting at the polygraphy the absence of night-respiratory disorders (AHI \< 10 / hour) and of Periodic Limbs Movements (PLMI \< 15 / hour), as well as the absence of restless legs syndrome at the interview,
  • Presenting to the MWT an excessive daytime sleepiness: mean latency \< 20 min,
  • Absence of syndrome of phase delay according to the criteria of l'ICSD2 (International Classification Sleep Disorders),
  • Having been schooled until class of 3rd,
  • Having regular schedules of life 4 days before going into the study,
  • Beneficiary of a national insurance scheme,
  • Having given in writing their informed consent to participate in the study.
  • For healthy subject:
  • Patients male or feminine, from 18 to 50 years old,
  • +9 more criteria

You may not qualify if:

  • Posted or night work,
  • Any evolutionary affection (Brain tumour, epilepsy, migraine, cerebral vascular accident, calcifies, myoclonia, chorea, neuropathy, muscular dystrophies, dystrophy myotonic…),
  • Psychiatric comorbidity: Current major depressive episode, current hypo obsessive or obsessive episode, schizophrenia,
  • Renal disorders (Renal insufficiency, nephrolithiasis...),
  • Endocrine pathologies (dysthyroidism, diabetes),
  • Drug addiction during the last 6 months,
  • Alcohol addiction during the last 6 months,
  • Dependence in the tetra-hydroxy-cannabinol during the last 6 months,
  • Long-term treatment by benzodiazepines,
  • Treatment by atomoxetine,
  • Pregnant and breast-feeding women,
  • People under supervision, guardianship,
  • Person incapable to give personally its consent,
  • Nobody in emergency situation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Bordeaux

Bordeaux, 33000, France

Location

Related Publications (1)

  • Bioulac S, Sagaspe P, Tron E, Benard A, Berthomier C, Brandewinder M, Philip P, Taillard J. Does Homeostatic Sleep Pressure Buildup Explain Objective Excessive Daytime Sleepiness in Adults With ADHD? An Exploratory Study. Front Psychiatry. 2021 Feb 19;12:586528. doi: 10.3389/fpsyt.2021.586528. eCollection 2021.

MeSH Terms

Conditions

Attention Deficit Disorder with HyperactivitySleepiness

Interventions

Neuropsychological Tests

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental DisordersSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Psychological TestsBehavioral Disciplines and Activities

Study Officials

  • Cyril CHAUFTON, Md

    University Hospital, Bordeaux

    PRINCIPAL INVESTIGATOR
  • Antoine BENARD, MD

    University Hospital, Bordeaux

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 5, 2014

First Posted

August 15, 2014

Study Start

September 2, 2014

Primary Completion

May 1, 2017

Study Completion

August 1, 2017

Last Updated

August 10, 2017

Record last verified: 2017-08

Locations